View Press Releases
-
ECI Announces New CEO Brijesh Patel
ECI (Enhanced Compliance Inc.), a leading provider of regulatory, quality and engineering services and solutions for the life sciences industries, today announced the appointment of Brijesh Patel as the company’s new Chief Executive Officer (CEO), replacing Hoyt Randall Smith, who has announced his retirement.
Aug 7, 2024
-
Software Supply Chain Innovator Endor Labs Unveils A New Way To Remediate Application Security Risks
Endor Labs, the leader in software supply chain security, today unveiled two groundbreaking capabilities that fix an expensive and time-consuming problem in the Software Composition Analysis (SCA) market.
Aug 6, 2024
-
Integrated DNA Technologies Bolsters Synthetic Biology Portfolio with Launch of Rapid Genes and Significant Upgrades to Gene Synthesis Offerings
Aug 5, 2024
-
Cresset® collaborates with global leaders Enamine to enable the design of exciting new Targeted Protein Degraders
Aug 4, 2024
-
Rho names renowned neurologist Andrew Feigin, MD, as Chief Medical Officer
Rho, a full-service contract research organization (CRO), has appointed leading neurologist Dr. Andrew Feigin as its new chief medical officer (CMO). In this pivotal global role, Dr. Feigin will provide strategic medical and operational expertise across multiple therapeutic areas, ensuring the integrity and safety of Rho’s clinical trials. Dr. Feigin's career is marked by groundbreaking contributions to neurology and clinical research. He served as the site principal investigator on more than 30 clinical trials, notably spearheading the first phase 1 clinical trial using gene therapy for Parkinson's disease. His prolific contributions to the field include over 150 peer-reviewed articles and numerous advisory board positions.
Aug 4, 2024
-
Indica Labs Announces Launch of AI-Powered Macrodissection Suite to Advance Molecular Pathology Workflows
Indica Labs has announced the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.
Jul 31, 2024
-
New Survey Shows Strong Patient Support for Personalized Obesity Interventions
Respondents ages 18 to 65 highlight urgency for medical recognition, scientifically proven interventions, and genetic testing for personalized obesity treatment.
Jul 31, 2024
-
1upHealth Launches Customer Advisory Board to Advance Industry-Wide Interoperability and Fuel Technological Innovation
Jul 31, 2024
-
AVIA’s Generative AI Strategic Collaborative Enters Phase 2, Accelerating Healthcare AI Adoption and Real-World Applications
Jul 30, 2024
-
Sapio Sciences and Zifo Announce Strategic Partnership
Jul 29, 2024
-
Phreesia Now Available on Oracle Healthcare Marketplace
Phreesia is now available on Oracle Healthcare Marketplace and can be integrated with the Oracle Health Electronic Health Record (EHR).
Jul 29, 2024
-
Ansa Biotechnologies Pushes Limits of Complex DNA Synthesis with Launch of New Commercial Products
Ansa Biotechnologies announced the commercial availability of its Ansa Clonal DNA and Ansa DNA Fragments.
Jul 29, 2024
-
Clinion Wins The Clinical Trials Arena Excellence Award 2024 for Innovation
Clinion, a Lifescience technology company based out of the US, UK and India, has won a category award in the 2024 Clinical Trials Arena Excellence Awards in the Innovation category for its eClinical Platform.
Jul 29, 2024
-
Intelliguard Announces Shane Smith as Chief Strategy Officer
Intelliguard, a provider of data integration and RFID-enabled medication management solutions, named Shane Smith its Chief Strategy Officer.
Jul 28, 2024
-
Clearwater Managed Cloud Services Help Healthcare Organizations Leverage the Power of Microsoft Azure with Reduced Risk
Jul 28, 2024
-
Creative Biostructure Provides a Wide Range of Plant Exosomes to Enhance Skincare Research
Jul 26, 2024
-
Creative Enzymes Redefines Sustainability in Enzyme Innovation with Yeast-Fermented Vegan Collagen
Jul 14, 2024
-
Inizio Engage and Nye Health form a strategic alliance to enhance patient support and outcomes
Jul 28, 2024
-
Creative Enzymes Unveils Semaglutide, a Promising Solution for Comprehensive Diabetes Management
Jul 25, 2024
-
AI for Good: Insilico Medicine Hosts IMGAIA Product Launch Event
Insilico Announces Sustainability Benchmarking Initiative and New Gen-AI Features of Pharma.AI Platform
Jul 23, 2024


